Etanercept in Rheumatoid Arthritis and Vascular Inflammation

NCT02109289 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Recruitment difficulties

Conditions

Rheumatoid Arthritis
Vascular Inflammation

Interventions

DRUG: etanercept

Sponsor

Innovaderm Research Inc.